Meeting
2018 ASCO Annual Meeting
A phase I study of the PI3K inhibitor buplarlisib (B) with concurrent chemoradiotherapy (CRT) in patients with high risk locally advanced squamous cell cancer of the head and neck (LASCCHN).
Authors
Jochen H. Lorch
Dana-Farber Cancer Institute, Boston, MA
Jochen H. Lorch , Roy B. Tishler , Nicole Grace Chau , Glenn J. Hanna , Guilherme Rabinowits , Jonathan Daniel Schoenfeld , Danielle Nina Margalit , Anne M. O'Neill , Donald Annino , Laura A Goguen , Ravi Uppaluri , Ethan James Harris , Alec Kacew , Julian Huang , Laura Ma , Patricia Mchugh , Robert I. Haddad
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Local-Regional Disease
Clinical Trial Registration Number
NCT02113878
Citation
J Clin Oncol 36, 2018 (suppl; abstr 6071)
DOI
10.1200/JCO.2018.36.15_suppl.6071
Abstract #
6071
Poster Bd #
59
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
ORCA-2: A phase I study of olaparib in addition to cisplatin-based concurrent chemoradiotherapy for patients with high risk locally advanced squamous cell carcinoma of the head and neck.
First Author: Martin David Forster
Poster
2023 ASCO Annual Meeting
XRay Vision: A phase 3 study of xevinapant plus radiotherapy (RT) for high-risk, cisplatin-ineligible patients with resected, locally advanced squamous cell carcinoma of the head and neck (LA SCCHN).
First Author: Robert L. Ferris
Poster
2022 ASCO Annual Meeting
The RADIO trial: Randomized assessment of cisplatin dosing interval for ototoxicity with curative concurrent chemo-radiation for locally advanced head and neck squamous cell carcinoma.
First Author: Sara Kuruvilla
Poster
2018 ASCO Annual Meeting
A phase I dose-finding study of metformin in combination with concurrent cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma.
First Author: Shuchi Gulati